Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Phase I study of high-dose ascorbic acid with mFOLFOX6 or FOLFIRI in patients with metastatic colorectal cancer or gastric cancer

Fig. 2

Mean plasma concentration–time curve of ascorbic acid after 0.2~1.5 g/kg administration to cancer patients (n = 3) on Day 1 (a) and Day 3 (b). After i.v. administration, the plasma concentrations of ascorbic acid rose gradually and peaked at 3 h. The Cmax, and AUC values of ascorbic acid displayed dose-dependent increases. Ascorbic acid concentrations in the high-dose groups remained at 10–20 mmol/L for approximately 3 h and showed no accumulation in the body during 3 daily administrations. Curves varying in linetypes and colors correspond to different administration dosages of ascorbic acid

Back to article page